AtlasClear Holdings, Inc. filed a Form 10-Q with the SEC on November 13, 2026, covering the quarterly period ended September 30, 2026, disclosing a net loss of $1,052,971 and reporting that NYSE American suspended trading of its common stock and commenced delisting proceedings on November 10, 2026.
Key Highlights
- Net loss of $1,052,971 for the three months ended September 30, 2026, compared to a net loss of $440,294 for the same period in 2025, according to the filing.
- Trading suspended and delisting commenced: On November 10, 2026, the company received notice from NYSE Regulation that it suspended trading and commenced proceedings to delist the common stock under Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the stock.
- OTC Pink Limited Market trading: Since November 11, 2026, the company's common stock has traded on the OTC Pink Limited Market, the filing disclosed.
- Total revenues of $5,394,111 for the three months ended September 30, 2026, up from $4,250,590 in the same prior-year period, driven in part by stock locate fees of $2,997,205 (none reported in 2025).
- Total expenses of $7,913,673 for the quarter, compared to $5,127,828 in the prior-year quarter, with data processing and clearing costs rising to $1,897,046 from $584,250.
- 151,838,744 shares of common stock, $0.0001 par value, issued and outstanding as of November 3, 2026.
- Total assets of $69,813,853 and total stockholders' equity of $20,712,520 as of September 30, 2026, per the condensed consolidated balance sheet.
AtlasClear Holdings Q1 FY2027 Financial Results and Delisting Notice
AtlasClear Holdings, Inc. (NYSE American:ATCH) reported a net loss of $1,052,971 for the three months ended September 30, 2026, widening from a net loss of $440,294 in the comparable prior-year period, according to the filing. Total revenues increased to $5,394,111 from $4,250,590, with stock locate fees of $2,997,205 representing a new revenue line not present in the prior-year quarter. Commission revenues declined to $1,736,434 from $2,334,389, and clearing fees fell to $101,786 from $714,349.
Total expenses rose to $7,913,673 from $5,127,828 year over year. The filing attributed significant portions of this increase to data processing and clearing costs of $1,897,046 (up from $584,250), regulatory, professional fees and related expenses of $1,302,136 (up from $250,573), and stock compensation expense of $606,740 (up from $155,411). Loss from operations was $(2,519,562), compared to $(877,238) in the same prior-year period. Total other income of $1,243,273 partially offset the operating loss, including a $665,192 change in fair value of the secured convertible note and a $249,000 change in fair value of earnout liability.
As of September 30, 2026, the company reported total assets of $69,813,853 and total liabilities of $49,101,333, leaving total stockholders' equity of $20,712,520. The accumulated deficit stood at $(139,002,298). Separately, the filing disclosed that on November 10, 2026, the company received notice from NYSE Regulation that it had suspended trading of its common stock and determined to commence delisting proceedings, citing Section 1003(f)(v) of the NYSE American Company Guide "due to the low selling price of the Company's common stock." The company stated it intends to request a review by the Listings Qualifications Panel, though it noted "there can be no assurance that any such appeal will be successful." Since November 11, 2026, the company's common stock has traded on the OTC Pink Limited Market.
What Was Disclosed
AtlasClear Holdings filed its quarterly report for the period ended September 30, 2026, disclosing a net loss of $1,052,971, increased revenues driven by stock locate fees, rising operating expenses, and a notice of trading suspension and delisting proceedings from NYSE American effective November 10, 2026.



Please wait processing your request...